Immunogenetic HLA markers of chronic viral hepatitides

Terapevticheskii Arkhiv

Volumn 77, Issue 2, 2005, Pages 54-59

  Popov, E A ^a   Levitan, B N ^a   Alekseev, L P ^a   Pronina, O A ^a   Suchkov, S V ^a  

^a NONE

Author keywords

Chronic viral hepatitis; HLA

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ALLELE; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CORRELATION ANALYSIS; DELTA AGENT HEPATITIS; HAPLOTYPE; HEPATITIS A; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RUSSIAN FEDERATION; STATISTICAL SIGNIFICANCE; VIRUS HEPATITIS;

CHRONIC DISEASE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS D; HEPATITIS, VIRAL, HUMAN; HLA ANTIGENS; HLA-C ANTIGENS; HUMANS; KAZAKHSTAN; RUSSIA;

EID: 17144383583     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hilleman M. R. Pathogeny, prophylaxis and therapy of a hepatitis B with a bowel in practical area. Vaccine 2001; 19: 1837-1848.
2. Chen C. J. Hepatitis B risk factors for liver cancer. Lancet Infect. Dis. 2002; 2: 879.
3. Tillmann H. L., Chen D. F., Trautwein C. et al. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 2001; 48(5): 714-718.